Microbiome changes: an indicator of Parkinson's disease?

Area of Science:

• Neuroscience
• Microbiology
• Gastroenterology

Background:

• Parkinson's disease (PD) involves dopaminergic neuron loss and alpha-synuclein (α-syn) inclusions.
• The gut microbiome's role in PD initiation and progression is increasingly recognized.
• Existing studies on gut microbiome alterations in PD show inconsistent results.

Purpose of the Study:

• To review current findings on gut microbiome changes in Parkinson's disease.
• To highlight discrepancies and contradictions in existing research.
• To discuss future research avenues for microbiome studies in PD.

Main Methods:

• Literature review of studies investigating the gut microbiome in Parkinson's disease patients.
• Analysis of reported changes in bacterial families and genera.
• Synthesis of conflicting findings regarding specific microbial taxa.

Main Results:

• Many studies report decreased Prevotellaceae and butyrate-producers (e.g., Roseburia, Faecalibacteria).
• Some studies indicate an increase in Akkermansia genus.
• Significant variability and contradictory findings exist across studies.

Conclusions:

• The gut microbiome is implicated in Parkinson's disease pathogenesis.
• Contradictory findings necessitate further rigorous research.
• Future studies should focus on standardized methodologies and larger cohorts to clarify the gut microbiome's role in PD.